Registered Kenya · PPB

OLCORT CREAM

HYDROCOTISONE

11008 HYDROCOTISONE 1% W/W GENERIC/BIOSIMILARS

What it does

Hydrocortisone is a medication that reduces inflammation and helps relieve symptoms associated with various conditions.

Commonly used for: skin inflammation, allergic reactions, eczema, psoriasis …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
11008
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
HYDROCOTISONE
Dosage form
HYDROCOTISONE 1% W/W
Strength
-
Pack size
15G
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Biopharma
Applicant / LTR
BIOPHARMA LIMITED.
Country of origin
LOCAL
Manufacturer location
Building No. 01, Road 01 Dhaka Housing Main Rd, Dhaka 1207, Bangladesh

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:30:44 · updated 2026-08-03 02:17:20

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Hydrocortisone is a medication that reduces inflammation and helps relieve symptoms associated with various conditions.

What it treats

  • skin inflammation
  • allergic reactions
  • eczema
  • psoriasis
  • rheumatoid arthritis

How it works

It works by suppressing the immune response and reducing inflammation in the body.

Who it's for

Hydrocortisone is for adults and children who have inflammation or allergic conditions that need treatment.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: hydrocotisone

Hydrocortisone is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. It is commonly used in the treatment of various conditions including adrenal insufficiency, inflammatory disorders, and certain autoimmune diseases. Hydrocortisone mimics the action of cortisol, a hormone produced by the adrenal glands, and helps regulate metabolism, immune response, and stress reactions.

Indications

  • Adrenal insufficiency (Addison's disease)
  • Inflammatory conditions (e.g., arthritis, dermatitis)
  • Allergic reactions
  • Autoimmune diseases (e.g., lupus, multiple sclerosis)
  • Certain cancers as part of chemotherapy regimens

Dosage

Children: Refer to BNF for Children for appropriate dosing information.

Adults: Dosage varies widely depending on the condition being treated. Refer to specific guidelines or BNF for precise dosing recommendations.

Mechanism of action

Hydrocortisone exerts its effects by binding to the glucocorticoid receptor, leading to the regulation of gene expression. This results in decreased production of pro-inflammatory cytokines and mediators, thus reducing inflammation and immune responses. It also promotes gluconeogenesis and affects protein and lipid metabolism.

Pharmacodynamics

Hydrocortisone demonstrates anti-inflammatory effects by inhibiting the migration of leukocytes and the accumulation of these cells at sites of inflammation. It also stabilizes lysosomal membranes, reducing the release of inflammatory mediators. Furthermore, it influences carbohydrate metabolism, increasing blood glucose levels through gluconeogenesis and glycogenolysis.

Pharmacokinetics

Hydrocortisone is rapidly absorbed following oral administration, with peak plasma concentrations occurring within 1-2 hours. It has a bioavailability of approximately 80%. The drug is highly protein-bound, primarily to corticosteroid-binding globulin and albumin. Metabolism occurs mainly in the liver via conjugation and oxidation, resulting in inactive metabolites that are excreted in the urine. The elimination half-life is approximately 1-2 hours, but effects can last longer due to receptor binding.

Contra-indications

  • Systemic fungal infections
  • Hypersensitivity to hydrocortisone or any component of the formulation

Adverse effects

  • Increased risk of infections
  • Cushing's syndrome
  • Hyperglycemia
  • Hypertension
  • Osteoporosis
  • Weight gain
  • Mood changes
  • Gastrointestinal disturbances

Interactions

  • Non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal adverse effects
  • Anticoagulants may have altered effects
  • Live vaccines may be less effective or increase the risk of infection

Precautions

  • Use with caution in patients with diabetes mellitus
  • Caution in patients with cardiovascular disease
  • Monitor for signs of infection
  • Taper dosage when discontinuing long-term therapy

Pregnancy

Hydrocortisone is classified as category C. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Hydrocortisone is excreted in breast milk. Caution should be exercised when administered to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Topical cream
  • Topical ointment
  • Oral tablet
  • Injection solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.